Ira Mellman

Ira Mellman is a distinguished immunologist who has bridged academic discovery with pharmaceutical development of cancer immunotherapies. His fundamental work on dendritic cell biology and antigen presentation has informed cancer vaccine design and understanding of anti-tumor immunity. At Genentech, Mellman leads cancer immunology research and has contributed to the development of checkpoint inhibitors and novel immunotherapy combinations.

Ira Mellman是一位杰出的免疫学家，他将学术发现与癌症免疫治疗的药物开发联系起来。他在树突细胞生物学和抗原呈递方面的基础工作为癌症疫苗设计和抗肿瘤免疫理解提供了信息。在基因泰克，Mellman领导癌症免疫学研究，并为检查点抑制剂和新型免疫治疗组合的开发做出了贡献。